FDA released guidance on Circumstances that Constitute Delay [Regulatives / Guidelines]

posted by drgunasakaran1  – 2014-11-03 18:18 (3432 d 15:25 ago) – Posting: # 13827
Views: 2,657

Dear all,

FDA released Guidance for Industry, Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection.

http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM360484.pdf

Dr S Gunasakaran MBBS MD
Disclaimer: The replies/posts are my personal opinions and it does not represent my company views on the same.

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,640 registered users;
74 visitors (0 registered, 74 guests [including 5 identified bots]).
Forum time: 09:44 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5